Crafton Biotechnology Co., Ltd.

Crafton Biotechnology Co., Ltd. is a pioneering mRNA company dedicated to developing innovative mRNA medicines and vaccines. Based in Nagoya and Tokyo, Japan, Crafton Biotechnology is committed to advancing healthcare through its proprietary mRNA technologies, including the novel cap analog PureCapⓇ, which enables Cap2 mRNA. These advancements hold the potential to create first-in-class and best-in-class mRNA treatments, characterized by high capping efficiency, superior protein translation activity, and enhanced safety profiles.

Crafton Biotechnology Co., Ltd. is also developing a chemically synthesized, non-IVT approach to mRNA production, further solidifying its position at the forefront of mRNA technology. The company is actively developing novel medicines and vaccines through its internal pipeline and strategic partnerships with academic institutions and biotech-pharma companies. With a commitment to innovation and collaboration, Crafton Biotechnology Co., Ltd. aims to address critical healthcare needs and improve patient outcomes worldwide.

The primary address of Crafton Biotechnology Co., Ltd. is 1 Furo-cho, Nagoya University Incubation Facility, Tokai National University, Chikusa-ku, Nagoya, Aichi 464-0814, JP, with an additional location in San Diego, CA, US. Crafton Biotechnology Co., Ltd. welcomes partnerships with CDMO companies interested in its cap analogs and other proprietary mRNA technologies. We invite the manager of Crafton Biotechnology Co., Ltd. to create a customized and exclusive company showcase and product listing on our platform.